🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to describe the safety profile of Avaxim 80U Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02011763
Treatments Being Tested
Background: Malaria affects many people in Mali and other parts of Africa....
Status
Completed
Location
Mrtc/Usttb
Start Date
2019-04-24
Trial ID
NCT03917654
Treatments Being Tested
The study is a prospective, single centre, double-blinded randomized contro...
Status
Completed
Location
Alberta Children's Hospital/University of Calgary
Start Date
2016-11-22
Trial ID
NCT02917577
Treatments Being Tested
The present study will explore the immunogenicity of AVAXIM™ 80U-Pediatric ...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00313950
Human papillomavirus (HPV) is a member of the Papillomaviridae family of DN...
Status
Completed
Location
McGill University - Division of Cancer Epidemiology
Start Date
2014-01
Trial ID
NCT01824537
Treatments Being Tested
The purpose of this study is to investigate the potential for co-administra...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01064141
Treatments Being Tested
This safety surveillance study is being conducted in accordance with Korea ...
Status
Completed
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01838070
This study is to assess the safety and immunogenicity of three consecutive ...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00735644
This trial will evaluate the safety and immunogenicity of: i) measles vacci...
Status
Unknown
Location
Chris Hani Baragwanath Academic Hospital; Nrf/Dst Vpd Rmpru
Start Date
2017-04-10
Trial ID
NCT03330171
Treatments Being Tested
This is a Phase IIb randomised controlled trial of the safety, immunogenici...
Status
Active Not Recruiting
Location
Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN)
Start Date
2025-12-15
Trial ID
NCT07183371